Akonni Licenses Biological Threat Materials from USAMRIID to Develop Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Akonni Biosystems today announced a licensing agreement with the US Army Medical Research Institute of Infectious Diseases, which will provide the molecular diagnostics firm access to nucleic acid sequences, primers, and probes for important biological threat agents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.